These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37578047)
1. A novel robust inhibitor of papain-like protease (PLpro) as a COVID-19 drug. Soleimani Asl S; Roozbahani MH J Biomol Struct Dyn; 2024 Aug; 42(13):6863-6870. PubMed ID: 37578047 [TBL] [Abstract][Full Text] [Related]
2. Reconstruction of the unbinding pathways of new inhibitors of the SARS-CoV-2 papain-like protease using molecular dynamics simulation. Rahebi P; Aryapour H J Biomol Struct Dyn; 2024 Sep; 42(14):7501-7514. PubMed ID: 37505097 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
4. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations. Holmes J; Islam SM; Milligan KA Viruses; 2024 May; 16(6):. PubMed ID: 38932170 [TBL] [Abstract][Full Text] [Related]
6. Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An Jamalan M; Barzegari E; Gholami-Borujeni F J Proteome Res; 2021 Jan; 20(1):1015-1026. PubMed ID: 33350309 [TBL] [Abstract][Full Text] [Related]
7. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study. Rahul S; Sarkar A J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069 [TBL] [Abstract][Full Text] [Related]
8. Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro. Liu X; Zheng M; Zhang H; Feng B; Li J; Zhang Y; Zhang J; Zhao N; Li C; Song N; Song B; Yang D; Chen J; Qi A; Zhao L; Luo C; Zang Y; Liu H; Li J; Zhang B; Zhou Y; Zheng J Antiviral Res; 2024 Aug; 228():105944. PubMed ID: 38914283 [TBL] [Abstract][Full Text] [Related]
9. Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro. Kiba Y; Tanikawa T; Kitamura M Biol Pharm Bull; 2024; 47(5):965-966. PubMed ID: 38763750 [TBL] [Abstract][Full Text] [Related]
10. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations. Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751 [TBL] [Abstract][Full Text] [Related]
12. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Shan H; Liu J; Shen J; Dai J; Xu G; Lu K; Han C; Wang Y; Xu X; Tong Y; Xiang H; Ai Z; Zhuang G; Hu J; Zhang Z; Li Y; Pan L; Tan L Cell Chem Biol; 2021 Jun; 28(6):855-865.e9. PubMed ID: 33979649 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease. Mirza MU; Ahmad S; Abdullah I; Froeyen M Comput Biol Chem; 2020 Dec; 89():107376. PubMed ID: 32979815 [TBL] [Abstract][Full Text] [Related]
14. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations. Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036 [TBL] [Abstract][Full Text] [Related]
15. Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation. Sohraby F; Aryapour H PLoS One; 2021; 16(5):e0251910. PubMed ID: 34010326 [TBL] [Abstract][Full Text] [Related]
16. Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2. Elekofehinti OO; Iwaloye O; Josiah SS; Lawal AO; Akinjiyan MO; Ariyo EO Mol Divers; 2021 Aug; 25(3):1761-1773. PubMed ID: 33201386 [TBL] [Abstract][Full Text] [Related]